אבוסינאגיס 50 מ"ג

Држава: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

PALIVIZUMAB 50 MG

Доступно од:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

АТЦ код:

J06BB16

Фармацеутски облик:

POWDER FOR SOLUTION FOR INJECTION

Пут администрације:

I.M

Произведен од:

ABBVIE S.R.L., ITALY

Терапеутска група:

PALIVIZUMAB

Терапеутске индикације:

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

Датум одобрења:

2010-07-01